Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 28734759

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2017 Sep
First author
Overman MJ

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Sep;18(9):1141-1142. doi: 10.1016/S1470-2045(17)30512-0.
    note
    Source null
    related pmid
    28734760
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Sep;18(9):510. doi: 10.1016/S1470-2045(17)30638-1.
    note
    Source null
    related pmid
    28884691
    relationship
    Erratum in

Authors and identifiers

  1. name
    Overman MJ
    type
    Author
  2. name
    McDermott R
    type
    Author
  3. name
    Leach JL
    type
    Author
  4. name
    Lonardi S
    type
    Author
  5. name
    Lenz HJ
    type
    Author
  6. name
    Morse MA
    type
    Author
  7. name
    Desai J
    type
    Author
  8. name
    Hill A
    type
    Author
  9. name
    Axelson M
    type
    Author
  10. name
    Moss RA
    type
    Author
  11. name
    Goldberg MV
    type
    Author
  12. name
    Cao ZA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Overman MJ
    type
    Author
  2. name
    McDermott R
    type
    Author
  3. name
    Leach JL
    type
    Author
  4. name
    Lonardi S
    type
    Author
  5. name
    Lenz HJ
    type
    Author
  6. name
    Morse MA
    type
    Author
  7. name
    Desai J
    type
    Author
  8. name
    Hill A
    type
    Author
  9. name
    Axelson M
    type
    Author
  10. name
    Moss RA
    type
    Author
  11. name
    Goldberg MV
    type
    Author
  12. name
    Cao ZA
    type
    Author
bibliography ids
  1. nci-bib-285dc357486d33c78de8c09f
book metadata
content sha256
7142b809172de914097680880b0834a09f37f834a677e0624e981c59f2675fa0
document type
citation
dois
  1. 10.1016/S1470-2045(17)30422-9
electronic publication date
display
2017 Jul 19
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28734759
immutable id
pubmed:28734759@7142b809172de914097680880b0834a09f37f834a677e0624e981c59f2675fa0
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
9
name
The Lancet. Oncology
nlm unique id
100957246
pages
1182-1191
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Sep;18(9):1141-1142. doi: 10.1016/S1470-2045(17)30512-0.
    note
    Source null
    related pmid
    28734760
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Sep;18(9):510. doi: 10.1016/S1470-2045(17)30638-1.
    note
    Source null
    related pmid
    28884691
    relationship
    Erratum in
outcomes validated
false
pmid
28734759
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
0283073b555f4737c19a753cea17c6e12e7eb857e6b5773ff98e92a411e3f137
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Sep
precision
month
year
2017
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28734759/
title
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.

Preserved source evidence · Independent clinical review pending · Not medical advice